Forging a healthier future through research: McGill University launches new Institute of Genomic Medicine
_Landmark donation from alumnus Dr. Victor Phillip Dahdaleh will accelerate advances in global health using genomic medicine to inform patient diagnosis and care_
A landmark donation to support McGill Universitys renowned genomics research and education programs from UK-based alumnus and long-time donor Dr. Victor Dahdaleh is a catalyst for advancements in genomics research. Thanks to gifts from Dr. Dahdaleh totalling more than $30 million, McGill will launch the VICTOR PHILLIP DAHDALEH INSTITUTE OF GENOMIC MEDICINE. Todays announcement, which coincides with McGills annual Homecoming festivities, caps off more than a year of Bicentennial celebrations and transformative expressions of philanthropic support in honour of McGills 200th anniversary. The announcement will take place on THURSDAY, OCTOBER 20, 2022, AT 11:00 A.M. ON THE TERRACE OF THE MCGILL GENOME CENTRE, LOCATED AT 740 DR. PENFIELD AVENUE, MONTREAL.
McGill has long been a leader in Canada and North America in the increasingly vital fields of RNA and genomics research. Dr. Dahdalehs investment will further cement the Universitys international leadership in genomics, while enabling the Institute to expand its high-impact research programs, invest in top talent, and train the next generation of world scientific leaders.
“On behalf of the McGill community, I would like to express my deep gratitude to Victor and Mona Dahdaleh for this visionary gift from a couple who have been great friends and loyal supporters of McGill for many years,” said Professor Christopher Manfredi, Interim Principal and Vice-Chancellor of McGill University. “Dr. Dahdalehs support will be a catalyst for advancements in genomics research that will improve health outcomes for communities around the world. Dr. Dahdalehs commitment to forging a healthier future through research is truly inspiring.”
NEXT-GENERATION DRUG DISCOVERY RESEARCH
The Institute will harness the interdisciplinary expertise and research infrastructure across McGills faculties to implement a full spectrum approach to genomic medicine, which draws on information from all of a persons genes and how they interact to inform an individuals clinical care. McGill researchers will lead breakthrough research aimed at the development of cutting-edge diagnostic tools, targeted treatments, and new pharmaceuticals and preventative vaccines. Additionally, the Institutes integral social sciences pillar will draw on expertise across the University to lead important research on the ethical, policy, and legal implications of genomic medicine.
“It is an honour to contribute to McGill Universitys world-leading genomics program,” said Dr. Dahdaleh. “I feel strongly that genomic medicine is the key to preventing, treating and one day curing many of the diseases that impact lives, families and communities around the world. Im proud to be a part of this important effort to improve worldwide health.”
In concert with the Faculty of Medicine and Health Sciences and affiliated hospitals within the McGill University Health Centre, the Institute will maximize opportunities for clinical interventions in high-priority fields where McGill is already an established leader – such as cancer, neuroscience and mental health, chronic inflammatory diseases, and infectious diseases, including COVID-19.
“Dr. Dahdalehs generous gift provides crucial resources to help us attract impactful young scientists, students and trainees from around the world and create the conditions for these scientists to pursue their research activities and have a global impact on public health,” said Mark Lathrop, Director of the Institute. The gift will also provide important support for leveraging additional grant funding for the Institute.
TRAINING STUDENTS FROM DIVERSE BACKGROUNDS
The Institutes training program will have a particular focus on training students from lower- and middle- income countries, a goal that is especially important for Dr. Dahdaleh, who has directed many of his philanthropic efforts toward providing scholarships and training opportunities for disadvantaged students at world-class universities, including the London School of Economics.
Likewise, Dr. Dahdalehs investment in genomic medicine at McGill is an extension of his exceptional legacy of supporting innovative global health and health science research in Canada and internationally. He has previously given more than $20 million to establish the Dahdaleh Institute for Global Health Research at his alma mater York University in Toronto. He is also a longstanding supporter of the National Heart and Lung Institute at Imperial College London, the British Heart Foundation, and Asthma + Lung UK, where he has contributed to leading-edge research into cardiovascular disease and cancer, including mesothelioma.
“Dr. Dahdaleh shares McGills commitment to propelling innovation in genomic medicine on a global scale to improve diagnosis, treatment and preventative healthcare,” said Philippe Gros, Deputy Vice-Principal, Research and Innovation; Professor, Department of Biochemistry; and founder and co-lead of the McGill Research Centre on Complex Traits. “With his support, the Institutes researchers will build new partnerships and deepen existing ties with leading genomics programs internationally, particularly in the UK, where McGill already works closely with researchers at the University of Oxford and Imperial College London, and Japan, where we share a joint PhD program with the University of Kyoto.”
ABOUT VICTOR DAHDALEH
Victor Dahdaleh is a leading Canadian entrepreneur and philanthropist, whose worldwide charitable work has supported education, health-related research, and social and economic development. Through the Victor Dahdaleh Foundation, he supports several scholarship programs for disadvantaged overseas students to study at top universities, opening the door to higher education in parts of the world where opportunities are limited. In addition, he has supported some of the worlds top centres of medical research, including several university health faculties, providing much needed funding to areas such as cardiovascular health, neuroscience, and global health and policy issues.
McGills largest donor from the UK, Dr. Dahdaleh has long been an active volunteer and supporter of the University. For nearly 30 years, he has served as a trustee of the UK-based McGill University Trust, which supports programs and initiatives across McGill, notably the McGill University Trust Scholarships for UK students wishing to study at the University. In 2007, he joined with the William J. Clinton Foundation and went on to establish the Victor Dahdaleh-Clinton Foundation Scholarship Program, which now provides 32 scholarships for outstanding undergraduates from low-income countries, in perpetuity. In 2016, he founded the Victor Dahdaleh Chair in Neuroscience to support an integrated approach to the study of chronic brain disease, incorporating neurology, psychiatry, and rehabilitation science, among other disciplines. More details about the Victor Dahdalehs Foundations philanthropic work are available here.
Dr. Dahdaleh is the owner and chairman of Dadco [est. 1915], a privately owned investment, manufacturing, and trading group. He is also an Honorary Fellow and governor of the London School of Economics, Fellow of the Duke of Edinburghs International Award, board member of the International Aluminium Institute, and a past president of the Canada-UK Chamber of Commerce.
ABOUT MCGILL UNIVERSITY
Founded in Montreal, Quebec, in 1821, McGill University is Canadas top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning three campuses, 11 faculties, 13 professional schools, 300 programs of study and over 39,000 students, including more than 10,400 graduate students. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue.
CONTACT: Cynthia Lee, Media Relations, McGill University, (514) 793-6753, cynthia.lee@mcgill.ca
View original content:https://www.prnewswire.co.uk/news-releases/forging-a-healthier-future-through-research-mcgill-university-launches-new-institute-of-genomic-medicine-301654534.html
OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender